# Tirzepatide vs Ozempic: Key Differences Explained

**By telos rx Editorial Team** · 2026-11-04

**Tirzepatide vs Ozempic comes down to mechanism. Ozempic is semaglutide, which acts on one hormone receptor. Tirzepatide acts on two, GIP and GLP-1. A licensed provider at [telos rx](https://telosrx.com/pages/tirzepatide) can help you compare.**

Both are once weekly injections. Both lower appetite and blood sugar. But they are different molecules with different labels. Here is a clear, side by side look at tirzepatide vs Ozempic.

## Tirzepatide vs Ozempic at a glance

| Feature | Ozempic | Branded tirzepatide | Compounded tirzepatide |
| --- | --- | --- | --- |
| Active ingredient | Semaglutide | Tirzepatide (Mounjaro, Zepbound) | Tirzepatide |
| Receptors targeted | GLP-1 | GIP and GLP-1 | GIP and GLP-1 |
| FDA status | FDA-approved for type 2 diabetes | Mounjaro: type 2 diabetes. Zepbound: weight management | Not FDA-approved |
| How it is taken | Weekly injection | Weekly injection | Weekly injection |
| Common side effects | Nausea, diarrhea, constipation | Nausea, diarrhea, constipation | Similar digestive effects |
| Boxed warning | Thyroid C-cell tumors | Thyroid C-cell tumors | Same class concerns apply |
| Maker | Novo Nordisk | Eli Lilly | Licensed compounding pharmacy |

One note before going further. Compounded tirzepatide is not the same product as Mounjaro or Zepbound. It shares the ingredient, not the FDA review.

## The main difference: one receptor or two

Ozempic copies GLP-1, a gut hormone. GLP-1 slows stomach emptying, boosts insulin after meals and quiets hunger signals.

Tirzepatide copies GLP-1 and also GIP. GIP is a second gut hormone involved in insulin release and fat metabolism. That dual action is the core of the tirzepatide vs Ozempic debate.

Researchers think the second pathway may add to the effect. It may also change how some people tolerate the drug.

## What each drug is FDA-approved for

Ozempic is FDA-approved for adults with type 2 diabetes. Its label also covers lowering certain heart and kidney risks in that group. It is not labeled for weight management.

Semaglutide for weight management is sold as Wegovy. Tirzepatide comes as Mounjaro for type 2 diabetes and Zepbound for chronic weight management.

So comparing tirzepatide vs Ozempic for weight often means comparing tirzepatide with semaglutide in general. For a brand to brand view, see [Mounjaro vs Ozempic](https://telosrx.com/blogs/glp1/mounjaro-vs-ozempic-comparison).

## Weight loss: what head to head research shows

The [SURMOUNT-5 trial in the New England Journal of Medicine](https://pubmed.ncbi.nlm.nih.gov/40353578/) compared the two drugs directly. It enrolled adults with obesity but without type 2 diabetes.

The study concluded that branded tirzepatide was superior to branded semaglutide for body weight and waist reduction at 72 weeks. Both groups mostly reported mild to moderate digestive side effects.

Keep three limits in mind. The semaglutide arm used Wegovy doses, not Ozempic. The trial used branded products. And averages do not predict your result, since response varies widely.

Compare your GLP-1 options with a provider

Share your history online. A licensed provider reviews it asynchronously and decides if tirzepatide fits, subject to medical approval by a licensed provider.

[See tirzepatide at telos rx](https://telosrx.com/pages/tirzepatide)

## Blood sugar control

Both drugs lower blood sugar. They raise insulin when glucose is high and lower glucagon. That is why both started as diabetes medicines.

If you have type 2 diabetes, your provider weighs your A1C, other medicines and hypoglycemia risk. Taking either with insulin or a sulfonylurea can raise the chance of low blood sugar.

## Side effects compared

The side effect lists look alike. The most common are:

-   Nausea and reduced appetite
-   Diarrhea or constipation
-   Vomiting and indigestion
-   Stomach pain and bloating

These tend to show up when a dose goes up. Slower steps often help. Rarer risks for both include pancreatitis, gallbladder problems and kidney strain from dehydration.

Both labels carry a boxed warning about thyroid C-cell tumors. People with a personal or family history of medullary thyroid carcinoma or MEN 2 should not use either. Our [tirzepatide side effects guide](https://telosrx.com/blogs/glp1/tirzepatide-side-effects) covers warning signs in detail.

## Dosing differences

Both start at a low dose and step up gradually. The steps and top doses differ, because the molecules are dosed differently.

That means a semaglutide dose does not convert neatly to a tirzepatide dose. Your provider sets the dose, the schedule and the pace. If you are moving between them, read [how to switch from semaglutide to tirzepatide](https://telosrx.com/blogs/glp1/how-to-switch-from-semaglutide-to-tirzepatide).

## Cost and access

Branded drugs can be costly without coverage. Insurance often limits Ozempic to type 2 diabetes.

Compounded tirzepatide is an option some people discuss with a provider. It is not FDA-approved. The FDA explains its [concerns about GLP-1 drugs used for weight loss](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss), including dosing errors. That is why you should only use a licensed pharmacy and a licensed prescriber.

At telos rx, compounded tirzepatide is as low as $139 per month, as of publication, per the [tirzepatide page](https://telosrx.com/pages/tirzepatide). Learn more in [what is compounded tirzepatide](https://telosrx.com/blogs/glp1/what-is-compounded-tirzepatide).

## Which is right for you?

There is no universal winner. A provider looks at your goals, health history, other medicines and past GLP-1 experience.

Someone who tolerated semaglutide well may stay on it. Someone looking at a dual action option may discuss tirzepatide. Either way, the choice is subject to medical approval by a licensed provider.

Start with a private online review

telos rx is asynchronous. Complete your intake on your time, and a licensed provider decides your plan, subject to medical approval by a licensed provider.

[Check tirzepatide eligibility](https://telosrx.com/pages/tirzepatide)

## Frequently Asked Questions

### Is tirzepatide stronger than Ozempic?

In the SURMOUNT-5 trial, branded tirzepatide produced greater average weight reduction than branded semaglutide in adults with obesity without diabetes. That trial used Wegovy doses, not Ozempic, and studied branded drugs, not compounded versions. Strength also is not everything. Tolerability, health history and cost shape which option a provider picks for you.

### Is Ozempic the same as semaglutide?

Ozempic is a brand name. Its active ingredient is semaglutide, and it is FDA-approved for adults with type 2 diabetes. Wegovy is a different semaglutide brand labeled for chronic weight management. Compounded semaglutide is not FDA-approved and is not the same product as either brand, even though the ingredient name matches.

### Can you switch from Ozempic to tirzepatide?

Many people do switch, but only under a provider's direction. Your provider decides when to stop one and start the other, and at what dose. The dose usually restarts low because the two drugs are not dosed the same way. Read our guide on switching from semaglutide to tirzepatide for the steps involved.

### Which has more side effects, tirzepatide or Ozempic?

Both mainly cause digestive side effects, such as nausea, diarrhea, constipation and vomiting. These are most common when a dose increases. Both labels also carry the same boxed warning about thyroid C-cell tumors. Individual tolerance varies, so neither option is reliably easier for everyone. Your provider adjusts the pace if side effects build.

### Is compounded tirzepatide the same as Mounjaro or Zepbound?

No. Mounjaro and Zepbound are FDA-approved branded tirzepatide products made by Eli Lilly. Compounded tirzepatide is not FDA-approved. It is prepared by a licensed pharmacy for an individual patient under federal compounding rules. The FDA does not review compounded drugs for safety, effectiveness or quality before they are dispensed.

### Do I need diabetes to get tirzepatide?

No. Mounjaro is labeled for type 2 diabetes, but Zepbound is FDA-approved for chronic weight management in eligible adults. With telos rx, a licensed provider reviews your intake, including weight, history and medicines. Treatment eligibility is subject to medical approval by a licensed provider and approval is not automatic.

_telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service._

Ready to see if it fits? [Start your private evaluation with telos rx](https://telosrx.com/pages/tirzepatide).

**Tags:** cc-17, compounded tirzepatide, content-calendar, GLP-1 comparison, Ozempic, semaglutide, tirzepatide

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/tirzepatide-vs-ozempic)
